Results 201 to 210 of about 277,876 (250)
Some of the next articles are maybe not open access.
Prevention of Graves’ ophthalmopathy
Best Practice & Research Clinical Endocrinology & Metabolism, 2012Smoking is the most important risk factor for the occurrence/progression of Graves' ophthalmopathy (GO), as well as for its lower/slower response to immunosuppression. Accordingly, refrain from smoking should be urged, both as primary prevention (removal of risk factors in Graves' patients without GO), secondary prevention (early detection and ...
openaire +3 more sources
Ocular immunology and inflammation, 2018
Purpose: To discuss the use of tocilizumab in mild to severe Graves’ ophthalmopathy as corticosteroid-adjunctive therapy. Methods: Retrospective case reports.
T. Maldiney, C. Deschasse, P. Bielefeld
semanticscholar +1 more source
Purpose: To discuss the use of tocilizumab in mild to severe Graves’ ophthalmopathy as corticosteroid-adjunctive therapy. Methods: Retrospective case reports.
T. Maldiney, C. Deschasse, P. Bielefeld
semanticscholar +1 more source
Euthyroid Graves’ ophthalmopathy
QJM: An International Journal of Medicine, 2023A Schattner +3 more
openaire +2 more sources
The risk factors for Graves’ ophthalmopathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 2021Jiamin Cao +4 more
semanticscholar +1 more source
Journal of pediatric ophthalmology and strabismus, 2018
PURPOSE To examine extraocular rectus muscle tendons in patients with Graves' ophthalmopathy using optical coherence tomography (OCT). METHODS This was a cross-sectional observational study conducted with 55 healthy controls, 45 patients with ...
L. De-Pablo-Gómez-de-Liaño +6 more
semanticscholar +1 more source
PURPOSE To examine extraocular rectus muscle tendons in patients with Graves' ophthalmopathy using optical coherence tomography (OCT). METHODS This was a cross-sectional observational study conducted with 55 healthy controls, 45 patients with ...
L. De-Pablo-Gómez-de-Liaño +6 more
semanticscholar +1 more source
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2017
Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease and the full clinical picture can impair the quality of life of the patients considerably. Active inflammation can often be effectively treated by intravenous steroids/immunosuppression, however does not lead to full remission, since inflammation rather quickly results
A, Eckstein +4 more
openaire +1 more source
Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease and the full clinical picture can impair the quality of life of the patients considerably. Active inflammation can often be effectively treated by intravenous steroids/immunosuppression, however does not lead to full remission, since inflammation rather quickly results
A, Eckstein +4 more
openaire +1 more source
CYCLOSPORIN IMPROVES GRAVES' OPHTHALMOPATHY
The Lancet, 1983Cyclosporin given to two patients with Graves' ophthalmopathy produced a rapid objective improvement in both, including restoration of ocular-muscle function and visual acuity, improvement in exophthalmos, and reduction in orbital muscle swelling judged by computed tomographic scan.
A P, Weetman +6 more
openaire +2 more sources
La Revue du praticien, 2005
Graves' ophthalmopathy (GO) is a chronic autoimmune process that affects the retrobulbar tissue and has strong etiological links with graves' disease. Pathogenesis is incompletely understood. Symptoms include proptosis, extraocular muscle dysfunction, eyelid swelling and retraction.
Isabelle, Badelon, Serge, Morax
openaire +1 more source
Graves' ophthalmopathy (GO) is a chronic autoimmune process that affects the retrobulbar tissue and has strong etiological links with graves' disease. Pathogenesis is incompletely understood. Symptoms include proptosis, extraocular muscle dysfunction, eyelid swelling and retraction.
Isabelle, Badelon, Serge, Morax
openaire +1 more source